Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current Assets:
Cash	$ 45	$ 22
Inventory	118	118
Total current assets	163	140
TOTAL ASSETS	163	140
Current Liabilities:
Accounts payable and accrued expenses	254,940	192,162
Settlement payable	9,501	9,501
Notes payable, current portion	7,531	7,361
Dividends payable	1,608	1,608
Total current liabilities	273,580	210,632
Long term notes payable, non current portion	24,629	24,799
Total long term liabilities	24,629	24,799
TOTAL LIABILITIES	298,209	235,431
Stockholders’ Equity (Deficit)
Common stock, $0.0001 par value, 500,000,000 shares authorized, 60,459,890 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	6,046	6,046
Additional paid in capital	3,429,694	3,389,954
Accumulated deficit	(3,591,267)	(3,488,889)
Minority interest	(142,519)	(142,402)
Total Stockholders’ Deficit	(298,046)	(235,291)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 163	$ 140

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.